Docket: Docket No. FDA-2025-D-2616

1 Federal Register document in this docket

Doc #	Type	Title	Published	Agency
2026-01068	Notice	Minimal Residual Disease and Complete Response in Multiple Myeloma: Use as Endpo...	Jan 21, 2026	Food and Drug Administration